Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Work In Process (2024 - 2025)

PROCEPT BioRobotics has reported Work In Process over the past 2 years, most recently at $12.8 million for Q3 2025.

  • Quarterly results put Work In Process at $12.8 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $12.8 million (changed N/A YoY), and the annual figure for FY2024 was $11.5 million, changed.
  • Work In Process for Q3 2025 was $12.8 million at PROCEPT BioRobotics, down from $13.0 million in the prior quarter.
  • Over the last five years, Work In Process for PRCT hit a ceiling of $13.0 million in Q2 2025 and a floor of $10.9 million in Q1 2025.